Eledon Pharmaceuticals (ELDN) Current Leases (2019 - 2026)
Eledon Pharmaceuticals (ELDN) posted Current Leases of $369000.0 for Q1 2026, up 3.07% on a QoQ basis from $358000.0 in Q4 2025, and up 13.54% year-over-year from $325000.0 in Q1 2025.
Eledon Pharmaceuticals (ELDN) Current Leases (2019 - 2026) Analysis & Trends
Eledon Pharmaceuticals' Current Leases history runs 8 years deep, the most recent figure standing at $369000.0 for Q1 2026.
- Quarterly Current Leases rose 13.54% year-over-year to $369000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $369000.0 (up 13.54% YoY) and the FY2025 annual result came in at $358000.0, up 14.01% from the prior year.
- Current Leases was $369000.0 for Q1 2026 at Eledon Pharmaceuticals, up from $358000.0 in the prior quarter.
- Across five years, Current Leases topped out at $396000.0 in Q3 2023 and bottomed at $186000.0 in Q3 2024.
- A 5-year average of $335058.8 and a median of $346000.0 in 2025 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2022 — Current Leases soared 238.14% — and 2024, when it plunged 53.03%.
- Eledon Pharmaceuticals' Current Leases stood at $363000.0 in 2022, then grew by 5.51% to $383000.0 in 2023, then decreased by 18.02% to $314000.0 in 2024, then gained by 14.01% to $358000.0 in 2025, then rose by 3.07% to $369000.0 in 2026.
- Business Quant data shows ELDN's Current Leases at $369000.0 in Q1 2026, $358000.0 in Q4 2025, and $346000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - | - |
| 4 | BeOne Medicines | 470.64 Bn | 465.84 Bn | 1.35 Bn | 20.58 Mn |
| 5 | Vertex Pharmaceuticals | 122.91 Bn | 115.67 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.07 Bn | 61.31 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.77 Bn | 62.77 Bn | - | - |
| 8 | Argenx Se | 56.21 Bn | 51.02 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.60 Bn | 37.60 Bn | - | 16.61 Mn |
| 10 | Eledon Pharmaceuticals | 406.41 Mn | 406.41 Mn | - | 369,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 369,000.00 |
| Dec 31, 2025 | 358,000.00 |
| Sep 30, 2025 | 346,000.00 |
| Jun 30, 2025 | 336,000.00 |
| Mar 31, 2025 | 325,000.00 |
| Dec 31, 2024 | 314,000.00 |
| Sep 30, 2024 | 186,000.00 |
| Jun 30, 2024 | 269,000.00 |
| Mar 31, 2024 | 284,000.00 |
| Dec 31, 2023 | 383,000.00 |
| Sep 30, 2023 | 396,000.00 |
| Jun 30, 2023 | 390,000.00 |
| Mar 31, 2023 | 384,000.00 |
| Dec 31, 2022 | 363,000.00 |
| Sep 30, 2022 | 378,000.00 |
| Jun 30, 2022 | 287,000.00 |
| Mar 31, 2022 | 328,000.00 |
| Dec 31, 2021 | 369,000.00 |
| Sep 30, 2021 | 177,000.00 |
| Jun 30, 2021 | 179,000.00 |